← Leaderboards
Kathryn A. Cunningham
University Of Texas Med Br Galveston
$26,840,884
Attributed
$37,885,686
Total exposure
25
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$48,736,728 · 27
By mechanism
R01$15,795,400 · 6
P50$9,205,982 · 3
P20$5,525,245 · 3
UG3$5,261,536 · 2
T32$3,663,596 · 1
RM1$3,486,352 · 1
Top collaborators
- Jia Zhou17 shared
- Scott R Gilbertson8 shared
- Jonathan Dean Hommel7 shared
- Ping Wu4 shared
- R. Dayne Mayfield3 shared
- Noelle C Anastasio2 shared
- Jeffrey J Borckardt2 shared
- Navid Khodaparast2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Jonathan Dean Hommel$4,897,281
- Allan R. Brasier$76,022,342
- Noelle C Anastasio$1,804,503
- Ping Wu$3,932,683
Others in their field
Top investigators on “Cocaine”
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Fred M Gordin · Social And Scientific Systems, Inc.$44,160,542
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,690,128
- Joel Gelernter · Washington University$34,364,949
- Michael A Nader · Emory University$33,226,167
- Shenghan Lai · University Of Miami Coral Gables$31,568,530
Research focus
CocainePharmaceutical PreparationsAddictionSerotoninRelapseBehavioralNeurobiologyRattusIn VivoBaseReceptorLigandsBrainPharmacologySelf AdministrationSignal TransductionBehaviorDesignInnovationAgonistResponseSuccessPhenotypeLink
Grant awards (136)
Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain$1,733,153
RM1 · FY2025 · NS
Mechanisms of prenatal opioid exposure on brain and behavior$631,388
R01 · FY2025 · DA
5-HT2 Receptor Allosterism in Cocaine Use Disorder$538,887
R01 · FY2025 · DA
Novel Addiction Neurocircuits in Cocaine Taking$488,840
R01 · FY2025 · DA
GPR6: A Circuit-Level Druggable Target in Cocaine Use Disorder$440,000
R21 · FY2025 · DA · contact PI
Translational Explorations in Substance Use Disorders$279,033
T32 · FY2025 · DA · contact PI
Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain$1,753,199
RM1 · FY2024 · NS
Mechanisms of prenatal opioid exposure on brain and behavior$631,388
R01 · FY2024 · DA
5-HT2 Receptor Allosterism in Cocaine Use Disorder$538,887
R01 · FY2024 · DA
Novel Addiction Neurocircuits in Cocaine Taking$488,840
R01 · FY2024 · DA
Translational Explorations in Substance Use Disorders$275,042
T32 · FY2024 · DA · contact PI
Mechanisms of prenatal opioid exposure on brain and behavior$631,388
R01 · FY2023 · DA
5-HT2 Receptor Allosterism in Cocaine Use Disorder$538,887
R01 · FY2023 · DA
Novel Addiction Neurocircuits in Cocaine Taking$488,840
R01 · FY2023 · DA
Translational Explorations in Substance Use Disorders$259,555
T32 · FY2023 · DA · contact PI
Mechanisms of prenatal opioid exposure on brain and behavior$631,388
R01 · FY2022 · DA
5-HT2 Receptor Allosterism in Cocaine Use Disorder$537,543
R01 · FY2022 · DA
Novel Addiction Neurocircuits in Cocaine Taking$488,840
R01 · FY2022 · DA
Neural and Pharmacological Mechanisms of Abused Drugs$73,565
T32 · FY2022 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$229,199
T32 · FY2021 · DA · contact PI
NOP Receptor Antagonist for OUD Pharmacotherapy$2,793,808
UG3 · FY2020 · DA · contact PI
Targeting the Ghrelin System for Novel Opioid Use Disorder Therapeutics$237,381
UG3 · FY2020 · DA · contact PI
BRD4 Inhibition for Opioid Pharmacotherapy$237,000
U18 · FY2020 · DA · contact PI
AMPAkines for Novel Opioid Use Disorder Pharmacotherapy$237,000
U18 · FY2020 · DA
Neural and Pharmacological Mechanisms of Abused Drugs$94,041
T32 · FY2020 · DA · contact PI
Targeting the Ghrelin System for Novel Opioid Use Disorder Therapeutics$2,230,347
UG3 · FY2019 · DA · contact PI
5âHT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER$477,285
R01 · FY2019 · DA
Neural and Pharmacological Mechanisms of Abused Drugs$310,433
T32 · FY2019 · DA · contact PI
5âHT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER$107,146
R01 · FY2019 · DA
5âHT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER$477,285
R01 · FY2018 · DA
Neural and Pharmacological Mechanisms of Abused Drugs$300,104
T32 · FY2018 · DA · contact PI
5-HT2CR Allosteric Modulators as Novel Pharmacotherapy in Cocaine Use Disorder$107,090
R01 · FY2018 · DA
Translational Addiction Sciences Center$1,387,621
P50 · FY2017 · DA · contact PI
5âHT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER$477,285
R01 · FY2017 · DA
Functional 5-HT2AR:5-HT2CR Imbalance in Impulsivity and Cue Reactivity$339,062
P50 · FY2017 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$292,587
T32 · FY2017 · DA · contact PI
Administration, Communication and Integration Core$243,336
P50 · FY2017 · DA · contact PI
Translational Addiction Sciences Center$16,934
P50 · FY2017 · DA · contact PI
5âHT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER$8,467
R01 · FY2017 · DA
Neural and Pharmacological Mechanisms of Abused Drugs$1
T32 · FY2017 · DA · contact PI
Translational Addiction Sciences Center$1,373,744
P50 · FY2016 · DA · contact PI
5âHT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER$510,641
R01 · FY2016 · DA
Functional 5-HT2AR:5-HT2CR Imbalance in Impulsivity and Cue Reactivity$335,674
P50 · FY2016 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$316,895
T32 · FY2016 · DA · contact PI
Administration, Communication and Integration Core$240,899
P50 · FY2016 · DA · contact PI
5âHT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER$8,899
R01 · FY2016 · DA
Translational Addiction Sciences Center$8,208
P50 · FY2016 · DA · contact PI
Translational Addiction Sciences Center$1,280,535
P50 · FY2015 · DA · contact PI
5âHT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER$436,045
R01 · FY2015 · DA
Functional 5-HT2AR:5-HT2CR Imbalance in Impulsivity and Cue Reactivity$247,962
P50 · FY2015 · DA · contact PI
Administration, Communication and Integration Core$172,200
P50 · FY2015 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$162,138
T32 · FY2015 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$114,647
K05 · FY2015 · DA · contact PI
Inhibitors of 5-HT2CR Protein:Protein Interactions for Stimulant Pharmacotherapy$7,927
R01 · FY2015 · DA · contact PI
Translational Addiction Sciences Center$1,297,576
P50 · FY2014 · DA · contact PI
Inhibitors of 5-HT2CR Protein:Protein Interactions for Stimulant Pharmacotherapy$368,411
R01 · FY2014 · DA · contact PI
Functional 5-HT2AR:5-HT2CR Imbalance in Impulsivity and Cue Reactivity$301,642
P50 · FY2014 · DA · contact PI
Administration, Communication and Integration Core$190,710
P50 · FY2014 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$114,647
K05 · FY2014 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$33,471
T32 · FY2014 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$1
T32 · FY2014 · DA · contact PI
Translational Addiction Sciences Center$1,292,984
P50 · FY2013 · DA · contact PI
Inhibitors of 5-HT2CR Protein:Protein Interactions for Stimulant Pharmacotherapy$353,738
R01 · FY2013 · DA · contact PI
Functional 5-HT2AR:5-HT2CR Imbalance in Impulsivity and Cue Reactivity$286,287
P50 · FY2013 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$263,736
T32 · FY2013 · DA · contact PI
Optimization of Allosteric Modulators of 5-HT2C Receptor$220,320
R21 · FY2013 · MH
Administration, Communication and Integration Core$190,608
P50 · FY2013 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$114,647
K05 · FY2013 · DA · contact PI
Inhibitors of 5-HT2CR Protein:Protein Interactions for Stimulant Pharmacotherapy$9,180
R01 · FY2013 · DA · contact PI
Translational Center on Serotonin and Stimulant Addiction$829,243
P20 · FY2012 · DA · contact PI
Inhibitors of 5-HT2CR Protein:Protein Interactions for Stimulant Pharmacotherapy$368,536
R01 · FY2012 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$263,736
T32 · FY2012 · DA · contact PI
Optimization of Allosteric Modulators of 5-HT2C Receptor$229,500
R21 · FY2012 · MH
5-HT2R NEUROBIOLOGY IN ANIMAL MODELS OF ADDICTION$166,124
P20 · FY2012 · DA · contact PI
Administration, Communication and Integration Core$125,908
P20 · FY2012 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$114,647
K05 · FY2012 · DA · contact PI
Inhibitors of 5-HT2CR Protein:Protein Interactions for Stimulant Pharmacotherapy$8,964
R01 · FY2012 · DA · contact PI
Inhibitors of 5-HT2CR Protein:Protein Interactions for Stimulant Pharmacotherapy$367,324
R01 · FY2011 · DA · contact PI
Blood and Brain Gene Profiling in Stimulant Self-Administration$181,977
R21 · FY2011 · DA
Addiction and the Neuropharmacology of Psychostimulants$114,647
K05 · FY2011 · DA · contact PI
Translational Center on Serotonin and Stimulant Addiction$829,243
P20 · FY2010 · DA · contact PI
Core Center for Translational Addiction Sciences$765,000
P30 · FY2010 · DA · contact PI
Inhibitors of 5-HT2CR Protein:Protein Interactions for Stimulant Pharmacotherapy$392,025
R01 · FY2010 · DA · contact PI
Neurobehavioral Pharmacology of Stimulants$348,189
R01 · FY2010 · DA · contact PI
Blood and Brain Gene Profiling in Stimulant Self-Administration$224,978
R21 · FY2010 · DA
5-HT2R NEUROBIOLOGY IN ANIMAL MODELS OF ADDICTION$166,994
P20 · FY2010 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$117,145
K05 · FY2010 · DA · contact PI
Administration, Communication and Integration Core$73,816
P20 · FY2010 · DA · contact PI
Translational Center on Serotonin and Stimulant Addiction$837,530
P20 · FY2009 · DA · contact PI
Core Center for Translational Addiction Sciences$765,000
P30 · FY2009 · DA · contact PI
Neurobehavioral Pharmacology of Stimulants$342,272
R01 · FY2009 · DA · contact PI
Blood and Brain Gene Profiling in Stimulant Self-Administration$202,500
R21 · FY2009 · DA
5-HT2R NEUROBIOLOGY IN ANIMAL MODELS OF ADDICTION$168,699
P20 · FY2009 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$117,145
K05 · FY2009 · DA · contact PI
Administration, Communication and Integration Core$74,559
P20 · FY2009 · DA · contact PI
Translational Center on Serotonin and Stimulant Addiction$837,809
P20 · FY2008 · DA · contact PI
Neurobehavioral Pharmacology of Stimulants$348,822
R01 · FY2008 · DA · contact PI
5-HT2R NEUROBIOLOGY IN ANIMAL MODELS OF ADDICTION$168,658
P20 · FY2008 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$117,145
K05 · FY2008 · DA · contact PI
Administration, Communication and Integration Core$74,565
P20 · FY2008 · DA · contact PI
Translational Center on Serotonin and Stimulant Addiction$859,615
P20 · FY2007 · DA · contact PI
Neurobehavioral Pharmacology of Stimulants$352,441
R01 · FY2007 · DA · contact PI
5-HT2R NEUROBIOLOGY IN ANIMAL MODELS OF ADDICTION$185,678
P20 · FY2007 · DA · contact PI
ADMINISTRATION, COMMUNICATION AND INTEGRATION CORE$126,804
P20 · FY2007 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$117,145
K05 · FY2007 · DA · contact PI
Neurobehavioral Pharmacology of Stimulants$333,172
R01 · FY2006 · DA · contact PI
Addiction and the Neuropharmacology of Psychostimulants$117,145
K05 · FY2006 · DA · contact PI
PHASE I, DOUBLE-BLIND, PLACEBO-CONTROLLED ASSESSMENT OF INTERATCIONS BETWEEN 2$314
M01 · FY2006 · RR · contact PI
NEUROPSYCHOPHARMACOLOGY MDMA--MONOAMINERGIC MECHANISMS$302,546
R01 · FY2005 · DA
Addiction and the Neuropharmacology of Psychostimulants$117,145
K05 · FY2005 · DA
Targeted Proteomics of Stress and Addiction$107,595
R21 · FY2005 · DA
PHASE I, DOUBLE-BLIND, PLACEBO-CONTROLLED ASSESSMENT OF INTERATCIONS BETWEEN 2$76,224
M01 · FY2005 · RR
NEUROPSYCHOPHARMACOLOGY MDMA--MONOAMINERGIC MECHANISMS$11,991
R01 · FY2005 · DA
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS$298,000
R01 · FY2004 · DA
NEUROPSYCHOPHARMACOLOGY MDMA--MONOAMINERGIC MECHANISMS$260,750
R01 · FY2004 · DA
NEURAL AND PHARMACOLOGICAL MECHANISMS OF ABUSED DRUGS$151,781
T32 · FY2004 · DA
Neuropsychopharmacol Interactions - Cocaine &Serotonin$124,393
K02 · FY2004 · DA
Targeted Proteomics of Stress and Addiction$120,589
R21 · FY2004 · DA
NEUROPSYCHOPHARMACOLOGY MDMA--MONOAMINERGIC MECHANISMS$54,546
R01 · FY2004 · DA
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS$298,000
R01 · FY2003 · DA
NEUROPSYCHOPHARMACOLOGY MDMA--MONOAMINERGIC MECHANISMS$260,750
R01 · FY2003 · DA
NEURAL AND PHARMACOLOGICAL MECHANISMS OF ABUSED DRUGS$174,430
T32 · FY2003 · DA
Targeted Proteomics of Stress and Addiction$135,275
R21 · FY2003 · DA
Neuropsychopharmacol Interactions - Cocaine &Serotonin$120,208
K02 · FY2003 · DA
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS$298,000
R01 · FY2002 · DA
NEUROPSYCHOPHARMACOLOGY MDMA--MONOAMINERGIC MECHANISMS$260,750
R01 · FY2002 · DA
Neuropsychopharmacol Interactions - Cocaine &Serotonin$118,241
K02 · FY2002 · DA
NEURAL AND PHARMACOLOGICAL MECHANISMS OF ABUSED DRUGS$62,685
T32 · FY2002 · DA
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS$20,804
R01 · FY2002 · DA
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS$323,000
R01 · FY2001 · DA
NEUROPSYCHOPHARMACOLOGY MDMA--MONOAMINERGIC MECHANISMS$252,126
R01 · FY2001 · DA
Neuropsychopharmacol Interactions - Cocaine &Serotonin$114,320
K02 · FY2001 · DA
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS$9,877
R01 · FY2001 · DA
NEUROBEHAVIORAL PHARMACOLOGY OF STIMULANTS$298,000
R01 · FY2000 · DA
NEURAL AND PHARMACOLOGICAL MECHANISMS OF ABUSED DRUGS$121,163
T32 · FY2000 · DA
COCAINE/SEROTONIN INTERACTIONS--NEUROPSYCHOPHARMACOLOGY$102,078
K02 · FY2000 · DA